Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects

被引:0
作者
Reza Elahi
Amir Hossein Heidary
Kaveh Hadiloo
Abdolreza Esmaeilzadeh
机构
[1] Zanjan University of Medical Sciences,School of Medicine
[2] Zanjan University of Medical Sciences,Department of Immunology
[3] Zanjan University of Medical Sciences,Cancer Gene Therapy Research Center (CGRC)
[4] Zanjan University of Medical Sciences,undefined
来源
Stem Cell Reviews and Reports | 2021年 / 17卷
关键词
Chimeric antigen receptor; Natural killer cell; Immunotherapy; Challenges; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2081 / 2106
页数:25
相关论文
共 307 条
[1]  
Di Maio M(2016)Perrone FJNrCo Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. 13 319-325
[2]  
Basch E(2018)Journal of Frontiers in immunology Immune cell hacking: Challenges and clinical approaches to create smarter generations of chimeric antigen receptor T cells. 9 1717-636
[3]  
Bryce J(2019)Journal of Stem Cell Reviews and Reports Solid tumors challenges and new insights of CAR T cell engineering. 15 619-1592
[4]  
Elahi R(2014)Moretta LJEjoi Effect of tumor cells and tumor microenvironment on NK-cell function. 44 1582-156
[5]  
Khosh E(2011)Madsen JCJCoiot Natural killer cells in rejection and tolerance of solid organ allografts. 16 47-444
[6]  
Tahmasebi S(2020)Stallone GJFiI The role of natural killer cells in the immune response in kidney transplantation. 11 1454-180
[7]  
Esmaeilzadeh A(2019)Maus MVJMT-M, Development C Engineering and design of chimeric antigen receptors. 12 145-4301
[8]  
Tahmasebi S(2019)Shpall EJJASoCOEB The other side of CAR T-cell therapy: Cytokine release syndrome, neurologic toxicity, and financial burden. 39 433-383
[9]  
Elahi R(2016)Curran KJJMT-O Toxicity and management in CAR T-cell therapy. 3 16011-1781
[10]  
Esmaeilzadeh A(2020)Wu CJCl CAR-NK for tumor immunotherapy: Clinical transformation and future prospects. 472 175-896